Clinical Trials List
2007-10-01 - 2009-12-31
Phase III
Terminated5
-
Trial Applicant
Astellas Pharma Inc.
-
Sponsor
-
Trial scale
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- MENG-KUN TSAI Division of General Surgery
- REY-HENG HU Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- YangJen Chiang Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Che-Chuan Loong Division of Urology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- CHENG-HSU CHEN Division of Nephrology
- Ming-Ju Wu Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shen-Shun Chang Division of General Surgery
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
60 participants
-
Global
0 participants
